Advertisement
Organisation › Details
FairJourney Biologics (FJB) (Group)
FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma. Founded in 2012 and headquartered in Porto, FairJourney has grown to over 90 highly technically skilled employees today. The Company operates a flexible, customer-oriented ‘one-stop shop’ approach to biologics development focused on quality, reliability and partnership. FairJourney has successfully completed more than 460 projects for over 70 customers across big pharma and leading biotech companies to date. The Company’s significant expertise in phage display technology, combined with a diverse approach to generating both immune and naïve antibody libraries have contributed to a market leading 99%+ project success rate. *
Start | 2012-01-01 established | |
Industry | contract manufacturing (biologicals) | |
Industry 2 | MAb | |
Person | Parada, António (Fairjourney Biologics 201303 CEO) | |
Region | Porto | |
Country | Portugal | |
City | n. a. | |
Address record changed: 2023-02-24 | ||
Basic data | Employees | B: 11 to 50 (2014-10-23) |
* Document for »About Section«: Iontas Ltd.. (5/13/20). "Press Release: FairJourney Biologics Joins Forces with Iontas to Create a Global Leader in Outsourced Antibody Discovery Services". Porto & Cambridge. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for FairJourney Biologics (FJB) (Group)
- [1] Orbit Discovery Ltd.. (6/29/21). "Press Release: Orbit Discovery Appoints Dr Neil Butt as Chief Executive Officer". Oxford....
- [2] Iontas Ltd.. (5/13/20). "Press Release: FairJourney Biologics Joins Forces with Iontas to Create a Global Leader in Outsourced Antibody Discovery Services". Porto & Cambridge....
- [3] Iontas Ltd.. (6/5/18). "Press Release: Iontas Signs Collaboration Agreement with LG Chem, Ltd. to Identify Therapeutic Oncology Leads". Cambridge & Seoul....
- [4] Iontas Ltd.. (5/30/18). "Press Release: Iontas Awarded £556K ($737K) from Innovate UK to Develop Therapies for Chronic Pain Management". Cambridge....
- [5] Iontas Ltd.. (5/2/18). "Press Release: Iontas and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads". Cambridge & Edinburgh....
- [6] Iontas Ltd.. (4/4/18). "Press Release: Iontas and Igem Therapeutics Collaborate to Identify Novel IgE Antibodies for Cancer Targets". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top